J. Teishima, “Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma ”, CUAJ, vol. 18, no. 5, pp. E162–6, Jan. 2024.